49 results
8-K
EX-1.1
SAGE
Sage Therapeutics Inc
7 Nov 23
Entry into a Material Definitive Agreement
7:39am
; the Company has taken all necessary actions to ensure that it will be in compliance with all applicable corporate governance requirements set forth
8-K
EX-3.1
SAGE
Sage Therapeutics Inc
16 Jun 23
Departure of Directors or Certain Officers
4:06pm
one or more committees, including, without limitation, a Compensation Committee, a Nominating and Corporate Governance Committee and an Audit Committee
DEFA14A
SAGE
Sage Therapeutics Inc
7 Jun 23
Additional proxy soliciting materials
4:05pm
outstanding shares and engaged with stockholders then representing approximately 67% of our outstanding shares to seek input on our corporate … governance and compensation matters. This feedback was reviewed and discussed with our Compensation Committee and resulted in a number of significant changes
8-K
EX-99.1
8oiy36lb6cr ap4gd
14 Jul 22
In the Court of Chancery of the State of Delaware
4:08pm